Galapagos expands its collaboration with Serono

21-Oct-2005

Galapagos announced that its services division BioFocus has reached agreement with the Swiss pharmaceutical company Serono to supply biologically-directed library compounds from its SoftFocus® collection throughout 2005-2006 for Serono's emerging drug discovery programs. Furthermore, medicinal chemistry services already being provided by BioFocus will be expanded further to accelerate Serono's existing programs.

The unique combination of BioFocus' and Serono's capabilities have proven to be highly fruitful, and it is envisaged that this increased collaboration will lead to further drug discovery programs between the two companies.

Under the terms of the agreement, Galapagos will receive technology access fees for library compounds, plus a fee-for-service component for medicinal chemistry services.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances